160 related articles for article (PubMed ID: 28316982)
1. Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance.
Kurtenkov O; Klaamas K
Biomed Res Int; 2017; 2017():6097647. PubMed ID: 28316982
[TBL] [Abstract][Full Text] [Related]
2. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O
World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858
[TBL] [Abstract][Full Text] [Related]
3. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients.
Kodar K; Kurtenkov O; Klaamas K
Immunol Invest; 2009; 38(8):704-17. PubMed ID: 19860583
[TBL] [Abstract][Full Text] [Related]
4. Signatures of anti-Thomsen - Friedenreich antigen antibody diversity in colon cancer patients.
Kurtenkov O; Bubina M; Klaamas K
Exp Oncol; 2018 Mar; 40(1):48-58. PubMed ID: 29600973
[TBL] [Abstract][Full Text] [Related]
5. Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.
Kurtenkov O; Klaamas K
Dis Markers; 2015; 2015():761908. PubMed ID: 26663951
[TBL] [Abstract][Full Text] [Related]
6. Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.
Kurtenkov O; Izotova J; Klaamas K; Sergeyev B
Biomed Res Int; 2014; 2014():830847. PubMed ID: 25276822
[TBL] [Abstract][Full Text] [Related]
7. The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer.
Kurtenkov O; Innos K; Sergejev B; Klaamas K
Biomed Res Int; 2018; 2018():9579828. PubMed ID: 30105268
[TBL] [Abstract][Full Text] [Related]
8. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival.
Kurtenkov O; Klaamas K; Mensdorff-Pouilly S; Miljukhina L; Shljapnikova L; Chuzmarov V
Acta Oncol; 2007; 46(3):316-23. PubMed ID: 17450466
[TBL] [Abstract][Full Text] [Related]
10. The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patients.
Smorodin E; Sergeyev B; Klaamas K; Chuzmarov V; Kurtenkov O
Int J Med Sci; 2013; 10(12):1674-82. PubMed ID: 24151439
[TBL] [Abstract][Full Text] [Related]
11. IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival.
Kurtenkov O; Klaamas K; Rittenhouse-Olson K; Vahter L; Sergejev B; Miljukhina L; Shljapnikova L
Exp Oncol; 2005 Jun; 27(2):136-40. PubMed ID: 15995632
[TBL] [Abstract][Full Text] [Related]
12. Natural IgM and IgG antibodies to Thomsen-Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors--relation to Lewis (a,b) histo-blood group phenotype.
Kurtenkov O; Miljukhina L; Smorodin J; Klaamas K; Bovin N; Ellamaa M; Chuzmarov V
Acta Oncol; 1999; 38(7):939-43. PubMed ID: 10606423
[TBL] [Abstract][Full Text] [Related]
13. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen.
Hanisch FG; Baldus SE
Histol Histopathol; 1997 Jan; 12(1):263-81. PubMed ID: 9046061
[TBL] [Abstract][Full Text] [Related]
14. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
[TBL] [Abstract][Full Text] [Related]
15. The relation of serum anti-(GalNAc beta) and -para-Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Chuzmarov VI; Afanasyev VP
Exp Oncol; 2007 Mar; 29(1):61-6. PubMed ID: 17431391
[TBL] [Abstract][Full Text] [Related]
16. The level of IgG antibodies reactive to TF, Tn and alpha-Gal polyacrylamide-glycoconjugates in breast cancer patients: relation to survival.
Smorodin EP; Sergeyev BL
Exp Oncol; 2016 Jun; 38(2):117-21. PubMed ID: 27356581
[TBL] [Abstract][Full Text] [Related]
17. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
[TBL] [Abstract][Full Text] [Related]
18. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.
Kurtenkov O
Biomed Res Int; 2020; 2020():9747040. PubMed ID: 32280709
[TBL] [Abstract][Full Text] [Related]
19. An increased level of the Concanavalin A-positive IgG in the serum of patients with gastric cancer as evaluated by a lectin enzyme-linked immunosorbent assay (LELISA).
Klaamas K; Kodar K; Kurtenkov O
Neoplasma; 2008; 55(2):143-50. PubMed ID: 18237253
[TBL] [Abstract][Full Text] [Related]
20. Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.
Flechner A; Butschak G; Löffler A; Rühmann J; Nishimura SI; Dölling R; Purfürst B; Goletz S; Danielczyk A; Karsten U
Int Immunopharmacol; 2019 Jul; 72():186-194. PubMed ID: 30999209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
